gri: the income statement

MyFinsight

GRI Bio, Inc. (GRI)

For the quarter ending 2025-06-30, GRI made $5K in revenue. -$2,892K in net income. Net profit margin of -57840.00%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	1,879
General and administrative	1,018
Total operating expenses	2,897
Loss from operations	-2,897
Interest income	5
Change in fair value of warrant liability	-
Net loss	-2,892

Net loss per share of common stock, basic (in usd per share)	-1.31
Net loss per share of common stock, diluted (in usd per share)	-1.31
Weighted-average common shares outstanding, basic (in shares)	2,205,139
Weighted-average common shares outstanding, diluted (in shares)	2,205,139

Unit: Thousand (K) dollars (except for numbers of shares and EPS)